Cargando…
Topical Drug Delivery to the Posterior Segment of the Eye
Topical drug delivery to the posterior segment of the eye is a very complex challenge. However, topical delivery is highly desired, to achieve an easy-to-use treatment option for retinal diseases. In this review, we focus on the drug characteristics that are relevant to succeed in this challenge. An...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779621/ https://www.ncbi.nlm.nih.gov/pubmed/35057030 http://dx.doi.org/10.3390/pharmaceutics14010134 |
_version_ | 1784637622116679680 |
---|---|
author | Löscher, Marina Seiz, Chiara Hurst, José Schnichels, Sven |
author_facet | Löscher, Marina Seiz, Chiara Hurst, José Schnichels, Sven |
author_sort | Löscher, Marina |
collection | PubMed |
description | Topical drug delivery to the posterior segment of the eye is a very complex challenge. However, topical delivery is highly desired, to achieve an easy-to-use treatment option for retinal diseases. In this review, we focus on the drug characteristics that are relevant to succeed in this challenge. An overview on the ocular barriers that need to be overcome and some relevant animal models to study ocular pharmacokinetics are given. Furthermore, a summary of substances that were able to reach the posterior segment after eye drop application is provided, as well as an outline of investigated delivery systems to improve ocular drug delivery. Some promising results of substances delivered to the retina suggest that topical treatment of retinal diseases might be possible in the future, which warrants further research. |
format | Online Article Text |
id | pubmed-8779621 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87796212022-01-22 Topical Drug Delivery to the Posterior Segment of the Eye Löscher, Marina Seiz, Chiara Hurst, José Schnichels, Sven Pharmaceutics Review Topical drug delivery to the posterior segment of the eye is a very complex challenge. However, topical delivery is highly desired, to achieve an easy-to-use treatment option for retinal diseases. In this review, we focus on the drug characteristics that are relevant to succeed in this challenge. An overview on the ocular barriers that need to be overcome and some relevant animal models to study ocular pharmacokinetics are given. Furthermore, a summary of substances that were able to reach the posterior segment after eye drop application is provided, as well as an outline of investigated delivery systems to improve ocular drug delivery. Some promising results of substances delivered to the retina suggest that topical treatment of retinal diseases might be possible in the future, which warrants further research. MDPI 2022-01-06 /pmc/articles/PMC8779621/ /pubmed/35057030 http://dx.doi.org/10.3390/pharmaceutics14010134 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Löscher, Marina Seiz, Chiara Hurst, José Schnichels, Sven Topical Drug Delivery to the Posterior Segment of the Eye |
title | Topical Drug Delivery to the Posterior Segment of the Eye |
title_full | Topical Drug Delivery to the Posterior Segment of the Eye |
title_fullStr | Topical Drug Delivery to the Posterior Segment of the Eye |
title_full_unstemmed | Topical Drug Delivery to the Posterior Segment of the Eye |
title_short | Topical Drug Delivery to the Posterior Segment of the Eye |
title_sort | topical drug delivery to the posterior segment of the eye |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779621/ https://www.ncbi.nlm.nih.gov/pubmed/35057030 http://dx.doi.org/10.3390/pharmaceutics14010134 |
work_keys_str_mv | AT loschermarina topicaldrugdeliverytotheposteriorsegmentoftheeye AT seizchiara topicaldrugdeliverytotheposteriorsegmentoftheeye AT hurstjose topicaldrugdeliverytotheposteriorsegmentoftheeye AT schnichelssven topicaldrugdeliverytotheposteriorsegmentoftheeye |